Chidozie Ugwumba sold $107k of HLSQ
other at BiomX Inc.. 277,247 shares at an average of $0.39, traded Sep 16, 2022, filed Nov 14, 2022.
Score components
- +8RoleOther
- +10Trade size$107k at market
- 0Share of holdings soldSold 8.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001014108-22-000162, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 16, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -3,200 | $0.51 | $1,642 | 3,346,027 | Nov 14, 2022 |
| Sep 19, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -13,870 | $0.49 | $6,727 | 3,332,157 | Nov 14, 2022 |
| Sep 20, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -10,626 | $0.45 | $4,792 | 3,321,531 | Nov 14, 2022 |
| Sep 21, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -5,574 | $0.43 | $2,380 | 3,315,957 | Nov 14, 2022 |
| Sep 22, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -17,388 | $0.41 | $7,181 | 3,298,569 | Nov 14, 2022 |
| Sep 23, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -5,306 | $0.37 | $1,984 | 3,293,263 | Nov 14, 2022 |
| Sep 26, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -17,528 | $0.36 | $6,222 | 3,275,735 | Nov 14, 2022 |
| Sep 27, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -4,866 | $0.33 | $1,611 | 3,270,869 | Nov 14, 2022 |
| Sep 28, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -15,649 | $0.33 | $5,211 | 3,255,220 | Nov 14, 2022 |
| Sep 29, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -3,300 | $0.35 | $1,152 | 3,251,920 | Nov 14, 2022 |
| Sep 30, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -8,662 | $0.36 | $3,084 | 3,243,258 | Nov 14, 2022 |
| Oct 3, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -15,022 | $0.33 | $4,957 | 3,228,236 | Nov 14, 2022 |
| Oct 4, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -19,200 | $0.34 | $6,605 | 3,209,036 | Nov 14, 2022 |
| Oct 5, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -46,785 | $0.44 | $20k | 3,162,251 | Nov 14, 2022 |
| Oct 6, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -25,098 | $0.44 | $11k | 3,137,153 | Nov 14, 2022 |
| Oct 7, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -24,708 | $0.36 | $8,845 | 3,112,445 | Nov 14, 2022 |
| Oct 10, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -10,043 | $0.33 | $3,274 | 3,102,402 | Nov 14, 2022 |
| Oct 11, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -5,988 | $0.33 | $1,988 | 3,096,414 | Nov 14, 2022 |
| Oct 12, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -9,700 | $0.33 | $3,230 | 3,086,714 | Nov 14, 2022 |
| Oct 13, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -11,314 | $0.33 | $3,734 | 3,075,400 | Nov 14, 2022 |
| Oct 14, 2022 | SOpen-market sale Common Stockindirect: By SymBiosis, LLC | -3,420 | $0.33 | $1,132 | 3,071,980 | Nov 14, 2022 |
Related signals
Other insiders at BiomX Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | HLSQsell BiomX Inc. | Reuven Yeganeh director, owner | $4.9M 980,000 shares | -218% | |
| 60Notable | HLSQsell BiomX Inc. | Reuven Yeganeh director, owner | $3.4M 670,000 shares | -223% | |
| 12Weak | HLSQsell BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | $9,280 24,344 shares | -0% | |
| 35Weak | HLSQsell BiomX Inc. | Assaf Oron Chief Business Officer | $4,072 10,914 shares | -100% | |
| 27Weak | HLSQbuy BiomX Inc. | OrbiMed Israel BioFund GP Limited Partnership owner | $85k 348,000 shares | +12% | |
| 20Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $184k 288,619 shares | -8% | |
| 13Weak | HLSQsell BiomX Inc. | Chidozie Ugwumba other | $27k 74,955 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.